Differentiated thyroid cancer in two European referral centres: impact of different diagnostic and therapeutic strategies

Differentiated thyroid cancer in two European referral centres: impact of different diagnostic and therapeutic strategies

Objective: To evaluate differences in the presentation, diagnostic/therapeutic approaches, and outcome of differentiated thyroid cancer (DTC) in an Italian and a Dutch referral centre. Methods: We retrospectively included 919 patients (586 Italian, 333 Dutch), and compared the two cohorts as a whole...

Full description

Saved in:

Bibliographic Details
Main Authors:	Daniele Ceruti, Petronella B Ottevanger, Simone De Leo, Han J Bonenkamp, Carla Colombo, Martin Gotthardt, Laura Fugazzola, Romana T Netea-Maier
Format:	Article
Language:	English
Published:	Bioscientifica 2025-08-01
Series:	European Thyroid Journal
Subjects:	thyroid cancer overdiagnosis outcome radioiodine thyroglobulin
Online Access:	https://etj.bioscientifica.com/view/journals/etj/14/4/ETJ-25-0161.xml
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of radioiodine therapy on preventing recurrence in differentiated thyroid carcinoma: a systematic review
by: Bima Indra, et al.
Published: (2025-05-01)

Clinical predictors of I-131 therapy failure in differentiated thyroid cancer by machine learning: A single-center experience
by: David J. Lubin, et al.
Published: (2021-07-01)

ANTI-THYROGLOBULIN ANTIBODIES IN PATIENTS WITH AUTOIMMUNE THYROIDITIS DURING L-THYROXINE TREATMENT
by: O. A. Shashkova, et al.
Published: (2014-07-01)

Value of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in staging of patients with differentiated thyroid cancer after thyroidectomy during the first course of radioiodine therapy
by: T. M. Geliashvili, et al.
Published: (2021-01-01)

Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy
by: Leo Hashimoto, et al.
Published: (2025-07-01)

The use of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in patients with differentiated thyroid cancer after initial treatment
by: T. M. Geliashvili, et al.
Published: (2017-04-01)

Thyroglobulin-to-tumor volume ratio combined with ultrasound features for diagnosing thyroid follicular neoplasms
by: Xixi Zhu, et al.
Published: (2025-07-01)

Diagnostic Value of Stimulated Serum Thyroglobulin in the Follow-up of Patients with Differentiated Thyroid Cancer
by: Vlado Wagenhofer, et al.
Published: (2024-01-01)

Thyroid testing in primary hypothyroidism
by: Anshula Ambasta, et al.
Published: (2025-06-01)

Prevalence of thyroid autoantibody positivity in women with infertility: a systematic review and meta-analysis
by: Yingqin Huang, et al.
Published: (2024-11-01)

Radioiodine-resistant metastases of well-differentiated thyroid cancer, analysis of tumor characteristics and primary surgical intervention
by: M. V. Ostafiychuk, et al.
Published: (2021-10-01)

CRITERIA OF WELL-DIFFERENTIATED THYROID CARCINOMA RESISTANCE TO RADIOIODINE THERAPY
by: P. O. Rumyantsev, et al.
Published: (2015-04-01)

Advanced metastatic radioiodine refractory differentiated thyroid cancer: current treatment and dynamic surveillance issues
by: E. V. Borodavina, et al.
Published: (2025-03-01)

Preradioactive Iodine Thyroglobulin Levels as Predictors of Metastasis in Well-Differentiated Thyroid Carcinoma Patients
by: Budi Darmawan, et al.
Published: (2022-12-01)

Guidelines for radioiodine therapy in differentiated thyroid cancer and post-therapeutic follow-up
by: A. Yu. Shurinov, et al.
Published: (2024-06-01)

Gender impact on safety and efficacy in lenvatinib treated patients with radioiodine-refractory differentiated thyroid cancer (GISEL study)
by: Giulia Puliani, et al.
Published: (2025-04-01)

Thyroglobulin measurement in the needle washout for diagnosis of lymph node metastases of differentiated thyroid cancer
by: N. V. Severskaya, et al.
Published: (2023-06-01)

Effect of age on the efficacy and safety of lenvatinib in radioiodine-refractory differentiated thyroid cancer in the phase III SELECT Trial
by: M. S. Brose, et al.
Published: (2018-07-01)

A rare case of minimally invasive follicular thyroid cancer with intraluminal superior vena cava and right atrium metastases
by: Alex Cheen Hoe Khoo, et al.
Published: (2019-07-01)

Analysis of malignancy predictors for follicular thyroid tumors
by: Zorić Goran V., et al.
Published: (2020-01-01)

Neoadjuvant target therapy of differentiated thyroid cancer (clinical observation)
by: P. A. Isaev, et al.
Published: (2017-04-01)

Experience in the use of targeted therapy in patients with radio-resistant forms of thyroid cancer in the Chelyabinsk Regional Clinical Center of Oncology and Nuclear Medicine
by: E. B. Vasil’eva, et al.
Published: (2018-04-01)

Low risk of thyroid eye disease (TED) following radioiodine (RAI) therapy in a multidisciplinary setting: a retrospective cohort study
by: John S. Vekinis, et al.
Published: (2025-08-01)

Elevated thyroglobulin levels in fine-needle aspiration washout fluid from thyroid nodules: a potential marker of benign nature?
by: Serhat Uysal, et al.
Published: (2025-08-01)

The correlation between thyroid status parameters and prolactin levels in reproductive-age women with autoimmune thyroiditis and subclinical hypothyroidism
by: Yu.V. Buldygina, et al.
Published: (2025-04-01)

The association between dietary sodium density and Hashimoto’s thyroiditis in US adults
by: Peilin An, et al.
Published: (2025-01-01)

RADIOIODINE THERAPY OF PAPILLARY THYROID CANCER, COMPLICATED BY A RADIAL MYELITIS. CLINICAL CASE
by: L. M. Farkhutdinova
Published: (2018-06-01)

Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer
by: Jan Taprogge, et al.
Published: (2025-07-01)

Acupuncture treatment for Hashimoto's thyroiditis: An exploratory randomized controlled trial
by: Shanze Wang, et al.
Published: (2024-03-01)

Comparison of radioiodine ablation rates between low versus high dose, and according to the surgeon's expertise in the low-risk group of differentiated thyroid cancer
by: Ghazal Norouzi, et al.
Published: (2021-03-01)

Failure of iodine uptake in microscopic pulmonary metastases after recombinant human thyroid-stimulating hormone stimulation
by: Courtney Lawhn-Heath, et al.
Published: (2020-01-01)

TSHR in thyroid cancer: bridging biological insights to targeted strategies
by: Shaojie Xu, et al.
Published: (2025-07-01)

RESULTS OF RESEARCH OF GALECTIN-3 AND THYROGLOBULIN IN PATIENTS WITH THYROID NODULES
by: O. S. Olifirova, et al.
Published: (2015-04-01)

Incidence of thyroid adverse events following immune checkpoint inhibitor treatment in patients with baseline positive thyroid antibodies: a systematic review and meta-analysis
by: Hui Yu, et al.
Published: (2025-07-01)

Ultrasound features and thyroid function of patients with papillary thyroid carcinoma for predicting metastatic cervical lymph nodes with atypical ultrasound features
by: Shuting Li, et al.
Published: (2025-08-01)

Vitamin D Deficiency in Iraqi Women with Hashimoto Thyroiditis
by: Kalaweesh Ali Mohamed, et al.
Published: (2025-04-01)

Metastatic papillary thyroid carcinoma presenting with elevated serum levels of carbohydrate antigen 19-9 (CA19-9): a case report
by: Minoru Kihara, et al.
Published: (2022-03-01)

Association Between Human Papillomavirus Vaccination and the Risk of Hashimoto’s Thyroiditis: A Cross-Sectional Study
by: Yifan Yin, et al.
Published: (2025-04-01)

“Tumour sink effect” on the diagnostic or posttreatment radioiodine scan due to sequestration into large-volume functioning metastasis of differentiated thyroid carcinoma influencing uptake in smaller metastatic sites or remnant thyroid tissue: An uncommon but possible phenomenon in thyroid cancer practice
by: Sandip Basu, et al.
Published: (2020-04-01)

Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation
by: Laura Musso, et al.
Published: (2025-03-01)